39097742|t|PPARgamma activation ameliorates cognitive impairment and chronic microglial activation in the aftermath of r-mTBI.
39097742|a|Chronic neuroinflammation and microglial activation are key mediators of the secondary injury cascades and cognitive impairment that follow exposure to repetitive mild traumatic brain injury (r-mTBI). Peroxisome proliferator-activated receptor-gamma (PPARgamma) is expressed on microglia and brain resident myeloid cell types and their signaling plays a major anti-inflammatory role in modulating microglial responses. At chronic timepoints following injury, constitutive PPARgamma signaling is thought to be dysregulated, thus releasing the inhibitory brakes on chronically activated microglia. Increasing evidence suggests that thiazolidinediones (TZDs), a class of compounds approved from the treatment of diabetes mellitus, effectively reduce neuroinflammation and chronic microglial activation by activating the peroxisome proliferator-activated receptor-gamma (PPARgamma). The present study used a closed-head r-mTBI model to investigate the influence of the TZD Pioglitazone on cognitive function and neuroinflammation in the aftermath of r-mTBI exposure. We revealed that Pioglitazone treatment attenuated spatial learning and memory impairments at 6 months post-injury and reduced the expression of reactive microglia and astrocyte markers in the cortex, hippocampus, and corpus callosum. We then examined whether Pioglitazone treatment altered inflammatory signaling mechanisms in isolated microglia and confirmed downregulation of proinflammatory transcription factors and cytokine levels. To further investigate microglial-specific mechanisms underlying PPARgamma-mediated neuroprotection, we generated a novel tamoxifen-inducible microglial-specific PPARgamma overexpression mouse line and examined its influence on microglial phenotype following injury. Using RNA sequencing, we revealed that PPARgamma overexpression ameliorates microglial activation, promotes the activation of pathways associated with wound healing and tissue repair (such as: IL10, IL4 and NGF pathways), and inhibits the adoption of a disease-associated microglia-like (DAM-like) phenotype. This study provides insight into the role of PPARgamma as a critical regulator of the neuroinflammatory cascade that follows r-mTBI in mice and demonstrates that the use of PPARgamma agonists such as Pioglitazone and newer generation TZDs hold strong therapeutic potential to prevent the chronic neurodegenerative sequelae of r-mTBI.
39097742	0	9	PPARgamma	Gene	19016
39097742	33	53	cognitive impairment	Disease	MESH:D003072
39097742	110	114	mTBI	Disease	
39097742	124	141	neuroinflammation	Disease	MESH:D000090862
39097742	223	243	cognitive impairment	Disease	MESH:D003072
39097742	284	306	traumatic brain injury	Disease	MESH:D000070642
39097742	310	314	mTBI	Disease	
39097742	317	365	Peroxisome proliferator-activated receptor-gamma	Gene	19016
39097742	367	376	PPARgamma	Gene	19016
39097742	481	493	inflammatory	Disease	MESH:D007249
39097742	588	597	PPARgamma	Gene	19016
39097742	746	764	thiazolidinediones	Chemical	MESH:D045162
39097742	766	770	TZDs	Chemical	MESH:D045162
39097742	825	842	diabetes mellitus	Disease	MESH:D003920
39097742	863	880	neuroinflammation	Disease	MESH:D000090862
39097742	933	981	peroxisome proliferator-activated receptor-gamma	Gene	19016
39097742	983	992	PPARgamma	Gene	19016
39097742	1034	1038	mTBI	Disease	
39097742	1081	1084	TZD	Chemical	MESH:C089946
39097742	1085	1097	Pioglitazone	Chemical	MESH:D000077205
39097742	1124	1141	neuroinflammation	Disease	MESH:D000090862
39097742	1164	1168	mTBI	Disease	
39097742	1196	1208	Pioglitazone	Chemical	MESH:D000077205
39097742	1238	1269	learning and memory impairments	Disease	MESH:D007859
39097742	1439	1451	Pioglitazone	Chemical	MESH:D000077205
39097742	1470	1482	inflammatory	Disease	MESH:D007249
39097742	1682	1691	PPARgamma	Gene	19016
39097742	1739	1748	tamoxifen	Chemical	MESH:D013629
39097742	1779	1788	PPARgamma	Gene	19016
39097742	1804	1809	mouse	Species	10090
39097742	1923	1932	PPARgamma	Gene	19016
39097742	2077	2081	IL10	Gene	16153
39097742	2083	2086	IL4	Gene	16189
39097742	2091	2094	NGF	Gene	18049
39097742	2238	2247	PPARgamma	Gene	19016
39097742	2279	2296	neuroinflammatory	Disease	MESH:D000090862
39097742	2320	2324	mTBI	Disease	
39097742	2328	2332	mice	Species	10090
39097742	2366	2375	PPARgamma	Gene	19016
39097742	2393	2405	Pioglitazone	Chemical	MESH:D000077205
39097742	2427	2431	TZDs	Chemical	MESH:D045162
39097742	2489	2506	neurodegenerative	Disease	MESH:D019636
39097742	2521	2525	mTBI	Disease	
39097742	Positive_Correlation	16189	19016
39097742	Negative_Correlation	MESH:D000077205	MESH:D007859
39097742	Positive_Correlation	16153	19016
39097742	Negative_Correlation	MESH:D000077205	MESH:D000090862
39097742	Association	MESH:D003072	19016
39097742	Negative_Correlation	MESH:D045162	MESH:D000090862
39097742	Negative_Correlation	MESH:D007249	19016
39097742	Positive_Correlation	18049	19016
39097742	Negative_Correlation	MESH:D000090862	19016
39097742	Negative_Correlation	MESH:D000077205	MESH:D019636
39097742	Negative_Correlation	MESH:D045162	MESH:D019636
39097742	Positive_Correlation	MESH:D045162	19016
39097742	Association	MESH:D013629	19016
39097742	Negative_Correlation	MESH:D045162	MESH:D003920

